Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for AnPac Bio-Medical Science Co., Ltd. Sponsored ADR (ANPC : NSDQ)
 
 • Company Description   
AnPac Bio-Medical Science Co., Ltd. is a biotechnology company focused on early cancer screening and detection. AnPac Bio-Medical Science Co., Ltd. is based in China.

Number of Employees: 86

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.29 Daily Weekly Monthly
20 Day Moving Average: 1,448,494 shares
Shares Outstanding: 14.76 (millions)
Market Capitalization: $4.35 (millions)
Beta: 1.56
52 Week High: $5.66
52 Week Low: $0.20
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -21.86% -11.99%
12 Week -56.92% -52.64%
Year To Date -75.83% -70.46%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
801 BIXING STREET BIHU COUNTY ZHEJIANG PROVINCE
-
LISHUI,F4 323006
CHN
ph: 86-57-8205-1666
fax: -
tina.xiao@ascent-ir.com http://www.anpacbio.com
 
 • General Corporate Information   
Officers
Chris Chang Yu - Co-Chairman
Aidong Chen - Co-Chairman
Edwards Jinqiu Tang - Chief financial officer
Xuedong Du - Vice president
Feng Guo - Director

Peer Information
AnPac Bio-Medical Science Co., Ltd. Sponsored ADR (CORR.)
AnPac Bio-Medical Science Co., Ltd. Sponsored ADR (RSPI)
AnPac Bio-Medical Science Co., Ltd. Sponsored ADR (CGXP)
AnPac Bio-Medical Science Co., Ltd. Sponsored ADR (BGEN)
AnPac Bio-Medical Science Co., Ltd. Sponsored ADR (GTBP)
AnPac Bio-Medical Science Co., Ltd. Sponsored ADR (RGRX)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 03635R107
SIC: 8071
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 09/01/21
Next Expected EPS Date: 05/26/22
Share - Related Items
Shares Outstanding: 14.76
Most Recent Split Date: (:1)
Beta: 1.56
Market Capitalization: $4.35 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 05/26/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 21.03
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: 26.47%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -37.73%
ROE
03/31/22 - -
12/31/21 - -
09/30/21 - -
ROA
03/31/22 - -
12/31/21 - -
09/30/21 - -
Current Ratio
03/31/22 - -
12/31/21 - -
09/30/21 - 0.35
Quick Ratio
03/31/22 - -
12/31/21 - -
09/30/21 - 0.34
Operating Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Net Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Pre-Tax Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Book Value
03/31/22 - -
12/31/21 - -
09/30/21 - 0.05
Inventory Turnover
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Equity
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Capital
03/31/22 - -
12/31/21 - -
09/30/21 - -
 

Powered by Zacks Investment Research ©